Health Care Originals (HCO), a leading digital health tech and wearable devices company that provides the only patch-type ambulatory cough monitor in the world, is pleased to announce a collaboration with Dr. Laurie Slovarp, of the University of Montana, who is pioneering a solution for people plagued with chronic cough.
Dr. Slovarp is an Associate Professor in the School of Speech, Language, Hearing, and Occupational Sciences at the University of Montana. She received a Master’s of Science degree in Speech and Hearing Sciences from Arizona State University in 2000 and a Ph.D. in Independent Interdisciplinary studies at University of Montana in August 2015. Dr. Slovarp has extensive experience as a medical speech-language pathologist. She is a swallowing and upper airway specialist and the director of the Voice Outcomes and Inquiry of Cough and Essentials in Swallowing (VOICES) lab. The mission of the VOICES lab is to conduct research that has a direct impact on clinical management and quality of life of patients with chronic cough and related upper airway disorders. Dr. Slovarp’s research has been supported through the Mountain West Clinical Translational Research Infrastructure Network (MW-CTRIN) and the Montana IDeA Network of Biomedical Research Excellence (INBRE) under grants from the National Institute of General Medical Sciences. Dr. Slovarp is currently conducting a clinical trial investigating a novel treatment for chronic refractory cough. The ADAMM-RSM will be used in her study to objectively measure cough frequency before and after treatment.
“I am excited about the potential of HCO’s ADAMM-RSM device – and its potential for helping us understand more about chronic cough, and other upper airway disorders,” said Dr. Slovarp. “It also has potential to improve diagnostic accuracy and treatment of these disorders.”
“We are delighted to collaborate with the University of Montana and Dr. Slovarp on this novel approach. As we are rolling out ADAMM-RSM in many clinical trials in respiratory diseases, we’re excited to continue to partner with researchers who understand the impact of cough and know that this previously unattainable data set will provide unparalleled insights. In particular, ADAMM-RSM’s value proposition – not visible, low burden of use naturally lends itself to gathering real-world evidence, which is of paramount importance when we think about better patient outcomes, and meaningful solutions that address real-world problems. Dr. Slovarp and her proposed work fit well within that framework, and HCO is honored to have Dr. Slovarp as a collaboration partner,” said Jared Dwarika, Co-Founder of HCO.
Source: Health Care Originals, Inc.
Be the first to comment